Tiina Kummik

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

Vija Skripconoka, Manfred Danilovitš, Lea Pehme et al. · European Respiratory Journal · 2012 · 341 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis

J. Peter Cegielski, Tracy Dalton, Martín Yagui et al. · Clinical Infectious Diseases · 2014 · 150 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +13

Inventory study of non-tuberculous mycobacteria in the European Union

Marieke J. van der Werf, Csaba Ködmön, Vera Katalinić-Jankovič et al. · BMC Infectious Diseases · 2014 · 104 citations · Full text

Public Health, Infectious Diseases, Microbiology +13

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance

J. Peter Cegielski, Ekaterina V. Kurbatova, Martie van der Walt et al. · Clinical Infectious Diseases · 2015 · 101 citations · Full text

Life Sciences, Pharmacology, Antimicrobial Pharmacotherapy +14

Availability and costs of medicines for the treatment of tuberculosis in Europe

Gunar Günther, Lorenzo Guglielmetti, Claude Leu et al. · Clinical Microbiology and Infection · 2022 · 49 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +12